A clinical report on the use of combined mandelamine and thiosulfil in resistant urinarv tract infections.
D003141:Communicable Diseases; D008333:Mandelic Acids; D008709:Methenamine / Q000628:therapy* / Q000031:analogs & derivatives; D009657:North Carolina; D013419:Sulfamethizole; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000628:therapy*; D014552:Urinary Tract Infections / Q000628:therapy*
D008333:Mandelic Acids; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D013419:Sulfamethizole; C023055:methenamine mandelate; D008709:Methenamine
METHENAMINE/therapy; SULFONAMIDES/therapy; URINARY TRACT INFECTIONS/therapy